Derek Wang | CEO
Bell Curve Capital

Derek Wang, CEO, Bell Curve Capital

Derek Wang, CEO of Bell Curve Capital, has over 15 years of experiences in option trading and quantitative research. He has worked at some of the leading trading firms in the world, including PEAK6, Ronin Capital and Capstone Investments.

In 2010, Derek founded Bell Curve Capital and built it into an efficient volatility trading firm with consistent profitable track records. He develops and manages the proprietary research process, volatility model, comprehensive trading tools, algorithmic trading, electronic execution technology (including several FIX engines connecting to major Wall Street firms), and risk management system and principles. 

Bell Curve has full automation from trading to operation, covering all liquid US equity options and corresponding equities. Derek has a PhD in Physics from University of Pennsylvania (1992).


TSC 2018 - DAY 2 @ 12:00

The quest for best ex and the alpha of trade performance – how are buy-side firms enhancing execution quality amidst changing market dynamics?

  • Buy-side control – what is driving buy-side firms to seek more power in the execution process? How will buy-side owned trading venues fit into the long-term picture for the equities market?
  • Cross-asset market microstructure – how are Reg NMS and MiFID II changing firms’ approach to sourcing liquidity? Has regulation ultimately improved or hindered execution?
  • Execution strategy – how are firms deploying algorithms in both dark and lit venues to locate the best price with minimal price leakage? 
  • Broker innovation – how are savvy brokers differentiating themselves to meet buy-side demands?
  • Clearing & settlement – is the post-trade process moving from a non-strategic necessity to a source of competitive differentiation?
  • Institutional vs. technical – how do execution needs differ between trading styles?
  • TCA & analytics – real-time analytics solutions to improve order routing and enhance execution quality

back to speakers